BiotechTube
Home/jCyte/Adrian Morris
AM

Adrian Morris

Chief Development Officer

jCyte

Therapeutic Areas

OphthalmologyRetinal DiseasesGenetic Disorders

jCyte Pipeline

DrugIndicationPhase
jCellRetinitis PigmentosaPhase 3
jCell (RPCs)Diabetic RetinopathyPreclinical

Leadership Team at jCyte

JS
John Sholar
Chief Executive Officer
HJ
Henry J. Klassen
Co-Founder and Chairman
JY
Jing Yang
Co-Founder and Chief Science Officer
RB
Rob Beathard
Chief Strategy Officer
View full jCyte profile